Showing results (1761-1770 of 2,464) with videos related to

Sort By:
Pageof 247
Drug Development Research|January 19, 2024
Two Distinct P2Y Receptors Are Involved in Purine- and Pyrimidine-Evoked Ca2+ Elevation in Mammalian Brain Astrocytic CulturesChiara Bolego, Carlo Centemeri, Maria P Abbracchio, et al.
Environmental Science & Technology|February 14, 2024
Advancing Global Health Surveillance of Mycotoxin Exposures using Minimally Invasive Sampling Techniques: A State-of-the-Science ReviewTyler A Jacobson, Yeunook Bae, Jasdeep S Kler, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2011
Protection from myocardial ischemia/reperfusion injury by a positive allosteric modulator of the A₃ adenosine receptorLili Du, Zhan-Guo Gao, Kasem Nithipatikom, et al.
Dementia and Geriatric Cognitive Disorders|February 2, 2011
The Montreal Cognitive Assessment and the mini-mental state examination as screening instruments for cognitive impairment: item analyses and threshold scoresAnne M Damian, Sandra A Jacobson, Joseph G Hentz, et al.
Journal of Medicinal Chemistry|February 2, 1996
Novel N6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A3 adenosine receptorsP G Baraldi, B Cacciari, G Spalluto, et al.
Pediatric Blood & Cancer|January 26, 2017
Implementing guidelines: Proposed definitions of neuropsychology services in pediatric oncologyKatherine T Baum, Stephanie K Powell, Lisa A Jacobson, et al.
Journal of Medicinal Chemistry|May 12, 1995
Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptorsK A Jacobson, S M Siddiqi, M E Olah, et al.
Neuropharmacology|November 10, 2024
MRS3997, a dual adenosine A2A/A2B receptor agonist, reduces brain ischemic damage and alleviates neuroinflammation in ratsIlaria Dettori, Irene Bulli, Martina Venturini, et al.
Pageof 247